Glaxo Seeks Indian Consumer Growth, Expanded Capacity
This article was originally published in The Tan Sheet
Executive Summary
GSK hopes to grow in all three of its business areas – consumer healthcare, pharmaceuticals and vaccines – in India with product introductions and a strategy to expand further into rural markets. CEO Andrew Witty previously headed Glaxo’s Asia Pacific operations and says he is a “huge bull on India.”